Krzysztof "Kris" Laudanski, MD, Ph.D., is an Assistant Professor in the Department of Anesthesiology and Critical Care at the University of Pennsylvania and Senior Fellow at the Leonard Davis Institute for Healthcare Economics. His research interests focus on regulating DNA expression in survivors after critical care illnesses, health care operations/medical decision-making processes, and healthcare innovation (artificial intelligence, nanotechnology). He is a PI on the NIH-funded grant, investigating abnormalities in gene regulation after critical care insult. Dr. Laudanski founded a start-up, Qbimm Diagnostic, a company oriented at diagnosing immune disorders using nanotechnology. He is also President of the Society for HealthCare innovation. Since his research showed that suboptimal decision-making processes might expose patients to unnecessary risks and that they may have negative economic consequences for hospital systems, he suggested, developed, and implemented artificial algorithms in critical care settings, integrating AI with wearable biosensors and predictive diagnostics. Adjusting health care operations and delivery based on availability, cultural specificity, and local demands is another area of interest that Kris frequently pursued. He is a committed mentor with several of his mentees attaining positions in academia (Stanford, Yale), private companies (Merck), or awarded prestigious scholarships (NSF).